Glaucoma News

An estimated 4.22 million U.S. adults had glaucoma in 2022, and 1.49 million had vision-affecting glaucoma, with “substantial variation” in prevalence by region and demographics, according to a study published in JAMA Ophthalmology.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Savak Teymoorian, MD, MBA, discusses the benefits of interventional glaucoma.

CHICAGO — Mitigating overtreatment in glaucoma requires a willingness to wait to treat patients, which can be cultivated by embracing the uncertainty of common glaucoma measurements, according to a speaker here.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Patrick Mooney, CEO of Spyglass Pharma, discusses the company’s IOL-based bimatoprost drug delivery platform for patients with open-angle glaucoma or ocular hypertension.

Use of glucagon-like peptide-1 receptor agonists was associated with a 19% reduction in risk for glaucoma in patients with type 2 diabetes, with longer use extending the protective association, according to a study in Ophthalmology.

Concurrent use of a beta-blocker with Simbrinza delayed the onset of ocular allergy and may extend treatment duration and adherence among patients with glaucoma, according to a retrospective study in BMC Ophthalmology.

Most patients with open-angle glaucoma responded favorably to repeat selective laser trabeculoplasty, regardless of initial response, and experienced a longer duration of effect, according to a study in JAMA Ophthalmology.

Dry eye disease is common in glaucoma patients treated with hypotonizing eye drops, with 56.1% of patients reporting subjective signs of dry eye, according to a study in the Open Journal of Ophthalmology.

Hormonal therapy may delay glaucoma onset in postmenopausal women, with longer duration of treatment linked to later diagnosis of glaucoma, according to a study in Investigative Ophthalmology & Vision Science.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Keith Barton, MD, speaks about the iTrack Global Data Registry, which collects real-world data on canaloplasty.